RDHL News and Press, Redhill Biopharma Ltd. From 08/17/23

2023-08-17 08:14:03 ET RedHill press release ( NASDAQ: RDHL ): 1H GAAP EPS of $0.04. Revenue of $5.4M (-82.8% Y/Y). Cash balance of $16.3 million as of June 30, 2023. For further details see: RedHill GAAP EPS of $0.04, revenue of $5.4M

RedHill Biopharma Provides H1/23 Financial Results and Operational Highlights PR Newswire RHB-107 included in the U.S. Department of Defense-supported ACESO PROTECT multinational platform trial for early COVID-19 outpatient treatment; The 300-patient Phase 2 study received FDA...

RedHill Biopharma Announces Talicia Approved in the United Arab Emirates and First Commercial Order Outside the U.S. PR Newswire RedHill's partner, Gaelan Medical, part of the Ghassan Aboud Group (GAG), receives marketing approval from the United Arab Emirates (UAE) Mi...

RedHill's RHB-107 Included in U.S. Government-Supported COVID-19 Platform Trial and Cleared for Initiation by FDA PR Newswire RHB-107 (upamostat) accepted for inclusion in ACESO's PROTECT adaptive platform trial for early COVID-19 outpatient treatment to be conducted in the U....

RedHill Biopharma Announces Closing of $3.8 Million Registered Direct Offering and Warrant Exercise PR Newswire TEL AVIV, ISRAEL , and RALEIGH, N.C. , July 25, 2023 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a spec...

2023-07-21 13:09:38 ET Gainers: Digital World Acquisition Corp. ( DWAC ) +47% . Quoin Pharmaceuticals ( QNRX ) +46% . 22nd Century Group ( XXII ) +41% . Guardforce AI Co ( GFAI ) +28% . Biodexa Pharmaceuticals Plc ( BDRX ) +25% ....

2023-07-21 10:22:31 ET Gainers: Quoin Pharmaceuticals ( QNRX ) +45% . Evelo Biosciences ( EVLO ) +24% . Biodexa Pharmaceuticals ( BDRX ) +19% . LifeMD ( LFMD ) +13% . BIMI International Medical ( BIMI ) +12% . Losers: ...

2023-07-21 10:09:32 ET RedHill Biopharma Ltd ( NASDAQ: RDHL ) on Friday announced that it has entered into agreements for the purchase and sale of 1,301,923 of company's American Depositary Shares ("ADSs") at a purchase price of $1.35 per ADS in a registered direct offering. E...

RedHill Biopharma Announces Registered Direct Offering and Warrant Exercise for $3.8 Million Gross Proceeds PR Newswire TEL AVIV, ISRAEL & RALEIGH, N.C. , July 21, 2023 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company")...

RedHill Announces Additional U.S. Government Funding for Opaganib Nuclear Countermeasure Development PR Newswire Opaganib awarded a further $1.7 million in U.S. Government funding for development as a medical countermeasure for gastrointestinal acute radiation syndrome (AR...